---
schema_version: "secwatch.filing_event.v1"
accession: "0001816590-22-000117"
form_type: "8-K"
ticker: "CMPS"
cik: "0001816590"
company_name: "COMPASS Pathways plc"
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T09:46:05.079724+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# COMPASS Pathways: Q3 net loss $18.4M ($0.43/share); Phase 3 program on track for 2022 start

## Summary
- Net loss of $18.4M in Q3 2022 vs. $15.8M in Q3 2021; cash $173.1M as of Sept 30, 2022.
- Phase 3 pivotal program for COMP360 in treatment-resistant depression on track to start in 2022.
- Phase 2b trial data published in The New England Journal of Medicine.
- Phase 2 trials ongoing in anorexia nervosa and PTSD; investigator-led study in autism launched.

## SEC filing metadata
- accession: 0001816590-22-000117
- form_type: 8-K
- ticker: CMPS
- cik: 0001816590
- company_name: COMPASS Pathways plc
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816590/000181659022000117/0001816590-22-000117-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816590/000181659022000117/cmps-20221103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001816590-22-000117
- JSON: https://secwatch.observer/filing/0001816590-22-000117.json
- Plain text: https://secwatch.observer/filing/0001816590-22-000117.txt

## Key facts
- Earnings Releases
  COMPASS Pathways plc reported three months and nine months ended September 30, 2022 results: net income Net loss for the three months ended 30 September 2022 was $18.4 million, or $0.43 loss per share, EPS $0.43 loss per share.
  - Period: three months and nine months ended September 30, 2022
  - Net income: Net loss for the three months ended 30 September 2022 was $18.4 million, or $0.43 loss per share
  - EPS: $0.43 loss per share
  - Result: reported results
  source text: Net loss for the three months ended 30 September 2022 was $18.4 million, or $0.43 loss per share (including non-cash share-based compensation expense of $3.5 million), compared with $15.8 million or $0.38 loss per share, during the same period in 2021
  evidence_url: https://www.sec.gov/Archives/edgar/data/1816590/000181659022000117/0001816590-22-000117-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.